Clinical trials are research studies that directly involve patients. They stem from a need to identify better treatments. They are the most responsible, coordinated way to evaluate the safety, effectiveness, dose, and outcomes for new therapies. Many of today's standard cancer treatments were first proven to be effective in carefully planned clinical trials. Want to participate in a study? Search the open clinical trials at Wilmot Cancer Institute.
Wilmot oncologists are currently testing two drugs for non-muscle invading bladder cancer: erlotinib and enzalutamide. Wilmot is also testing certain diagnostic tools, and conducting studies on a class of immune therapies called checkpoint inhibitors for metastatic cancer.